Higgins Jack 4
4 · Immunome Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Higgins Jack
Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2023-12-01+200,000→ 200,000 totalExercise: $7.80Exp: 2033-11-30→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]On December 1, 2023, Dr. Higgins was granted an option to purchase 200,000 shares of common stock. The option vests (i) with respect to 100,000 shares, 25% of such shares subject to the option, vest on November 17, 2024, and the remaining shares will vest monthly thereafter over three years, and (ii) with respect to the remaining 100,000 shares, which vesting shall commence as of the date a certain condition set forth in Dr. Higgins' Amended and Restated Offer Letter dated November 30, 2023, is satisfied, 25% of the shares subject to the option will vest 1 year from the completion of that certain condition, and the remaining shares will vest monthly thereafter over three years.